Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while understanding key product quality attributes that make them suitable for good manufacturing practice (GMP) production is important for the successful development of these therapeutics and vaccines.

Download the following two white papers to help you recognize major impurities and identify quality attributes when looking for GMP-quality NTPs.

  • Impurity profiling and analysis of TheraPure GMP* nucleotides
  • Quality and consistency of N1-methylpseudouridine triphosphate
 In early stages (research & discovery)
 Investigating solutions
 Actively establishing
 Already performing
 Not working in mRNA production

Would you like to discuss mRNA therapeutics solutions with a Thermo Fisher representative?*


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.